Do non-cardiac comorbidities impact quality of life and mortality in patients with HFrEF, HFmrEF, and HFpEF?
Patients with heart failure with reduced, mid-range, and preserved ejection fraction
Quality of life (QoL) and mortality risks
Non-cardiac comorbidities are highly prevalent in HFpEF and significantly worsen quality of life and mortality, with specific impacts varying by heart failure subtype.
The highest prevalence of comorbidities was seen in patients with HFpEF. Overall, comorbidities were associated with a lower QoL, but this was more pronounced in patients with HFrEF. Most comorbidities were associated with higher mortality risks, although the associations with diabetes were only present in patients with HFrEF.
Building similarity graph...
Analyzing shared references across papers
Loading...
Koen W. Streng
University Medical Center Groningen
Jan F. Nauta
University Medical Center Groningen
Hans L. Hillege
Heart Failure & Transplant
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)
International Journal of Cardiology
Inserm
Imperial College London
University of Groningen
Building similarity graph...
Analyzing shared references across papers
Loading...
Streng et al. (Sat,) studied this question.
synapsesocial.com/papers/69d56e0f75589c71d767d332 — DOI: https://doi.org/10.1016/j.ijcard.2018.04.001